New Key Statistics Module, Z-Score and F-Score
NAS:CTKB Key Ratios
| Market Cap $ M | 392.64 |
| Enterprise Value $ M | 146.73 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 254.50 |
| Price/Book | 1.04 |
| Price/Sales | 2.02 |
| Price/Free Cash Flow | 23.84 |
| Price/Owner Earnings | 88.56 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 197.00 |
| EPS (TTM) $ | -0.09 |
| Beneish M-Score | -2.84 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.39 |
| EV-to-EBITDA | -12.20 |
| PEG | -- |
| Shares Outstanding M | 126.66 |
| Net Margin (%) | -5.71 |
| Operating Margin % | -12.57 |
| Pre-tax Margin (%) | -4.05 |
| Quick Ratio | 4.95 |
| Current Ratio | 5.62 |
| ROA % (ttm) | -2.30 |
| ROE % (ttm) | -2.90 |
| ROIC % (ttm) | -17.29 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.31 |
CTKB Number of Guru Trades
CTKB Volume of Guru Trades
Gurus Latest Trades with NAS:CTKB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTKB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cytek Biosciences Inc Insider Transactions
No Available Data
News about NAS:CTKB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers